Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAPATINIB DITOSYLATE Cause Deep vein thrombosis? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Deep vein thrombosis have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 0.2% of all adverse event reports for LAPATINIB DITOSYLATE.

6
Reports of Deep vein thrombosis with LAPATINIB DITOSYLATE
0.2%
of all LAPATINIB DITOSYLATE reports
5
Deaths
5
Hospitalizations

How Dangerous Is Deep vein thrombosis From LAPATINIB DITOSYLATE?

Of the 6 reports, 5 (83.3%) resulted in death, 5 (83.3%) required hospitalization.

Is Deep vein thrombosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does LAPATINIB DITOSYLATE Cause?

Diarrhoea (893) Death (665) Nausea (317) Fatigue (301) Vomiting (259) Rash (249) Drug ineffective (183) Malignant neoplasm progression (183) Off label use (141) Disease progression (137)

What Other Drugs Cause Deep vein thrombosis?

LENALIDOMIDE (3,286) RIVAROXABAN (3,180) TESTOSTERONE (2,213) APIXABAN (1,944) ETHINYL ESTRADIOL\ETONOGESTREL (1,577) RITUXIMAB (1,287) METHOTREXATE (1,146) DROSPIRENONE\ETHINYL ESTRADIOL (1,139) DEXAMETHASONE (1,067) ADALIMUMAB (1,056)

Which LAPATINIB DITOSYLATE Alternatives Have Lower Deep vein thrombosis Risk?

LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN LAPATINIB DITOSYLATE vs LARONIDASE LAPATINIB DITOSYLATE vs LAROTRECTINIB LAPATINIB DITOSYLATE vs LASILIX LAPATINIB DITOSYLATE vs LASIX

Related Pages

LAPATINIB DITOSYLATE Full Profile All Deep vein thrombosis Reports All Drugs Causing Deep vein thrombosis LAPATINIB DITOSYLATE Demographics